Date: Oct 25, 2017 08:00 AM - 05:30 PM
Registration closes on Oct 24, 2017 11:00 PM
American Health Resources is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education
Requirements for CE Credit
- Participant Requirement and Statement of Credit: To receive credit, participants must fully attend each session (no partial credit will be awarded), pass in a completed attendance verification form, and using the access code provided, complete the online evaluation for each session attended. Attendance will be verified. All participants will have the opportunity to evaluate the educational sessions and presenters as well as the ability to identify their future educational needs.
- Pharmacists: CE credit will be automatically uploaded to CPE Monitor upon completion of the evaluation and posted to the participant’s NABP account within 72 hours where an official certificate of credit can be printed. Evaluations must be completed within 60 days of program date to receive credit.
- Statement of Disclosure: Disclosure will be made on the day of the program regarding any interest or affiliation a speaker may have with a supporting organization.
- Refund Policy: A full refund will be provided only if a written request is received by American Health Resources, Inc. at least 48 hours prior to the program or if the program is cancelled. American Health Resources, Inc. reserves the right to change the presenters, topics or seminar schedules.
- Describe the epidemiology, etiology, pathophysiology and diagnostic work-up for patients with celiac disease and the difference between celiac disease and non-celiac gluten sensitivity.
- Discuss the relationship between common misdiagnoses in patients with celiac disease, disorders “caused” by celiac disease and disorders “associated” with celiac disease.
- Recognize how medications may be a “hidden” and potentially significant source of gluten and how to check for the gluten content of medications.
- Explain why patients with celiac disease must maintain a strict life-long gluten-free diet/lifestyle.
- Review acute and long-term health issues associated with celiac disease and how the pharmacist may assist patients in managing these concerns.
- Discuss research being done on new therapeutic interventions for the management of celiac disease.
Robert Mangione, EdD, RPh
- Describe the interaction between the patient, the organism and the antimicrobial agent as it applies to an appropriate outcome for the patient.
- Identify significant patient factors as they pertain to this population.
- List the common microbes associated with infections in humans.
- Discuss the selection of an appropriate antibiotic regimen based on efficacy, toxicity and cost considerations.
- Establish monitoring parameters for each patient.
- Discuss the rationale and expectations of an antimicrobial stewardship program.
Joseph Brocavich, PharmD
- Compare, contrast and apply newly released American Diabetes Association and American Association of Clinical Endocrinologists guidelines for glycemic management in patients with type 2 diabetes.
- Describe the pharmacokinetic and pharmacodynamic differences of the SGLT-2 inhibitors, GLP-1RAs, DPP4 inhibitors, and basal insulins, and their roles within the guidelines.
- Evaluate current data of combination therapy, including fixed-ratio agents, based on efficacy, dosage form, and complementary actions.
- Utilizing patient cases, formulate evidence-based treatment regimens that optimize both fasting and post-prandial glucose and A1C reduction.
Jennifer Goldman, PharmD, CDE, BC-ADM, FCCP
Brief Bio : Dr. Goldman has been a pharmacist for over 20 years and joined the faculty at MCPHS University in 1997. She is a Professor of Pharmacy Practice and coordinates and teaches in various therapeutics courses. She has maintained a practice in primary care and family medicine with a specialty in diabetes and cardiovascular disease since 1997 and currently takes students on rotation at Well Life Medical in Peabody, MA where she practices as a clinical pharmacist and certified diabetes educator (CDE). She is on state-wide and national organizational committees and boards including but not limited to The Massachusetts Adult Diabetes Guidelines Working Group for the Diabetes Prevention and Control Program at the Department of Public Health in Massachusetts. She has been the recipient of the Long Term Service, Trustees Award for Teaching Excellence, The Preceptor of the Year, and the Pharmacy Practice Teacher of the year at MCPHS University and has been recognized by the American Academy of Family Physicians for teaching in Family Medicine. Her primary research interests are in the areas of diabetes, cardiovascular disease and teaching.
- Estimate the incidence of medical errors and their contribution to morbidity and mortality in the United States.
- Differentiate between human error, at-risk behavior, and reckless behavior with regards to medical errors.
- Explain how differences in human perception may result in medication errors.
- Discuss means of avoiding errors due to look-alike, sound-alike medications.
- Explain how the implementation of technology can introduce new errors into pharmacy practice.
Joseph Etzel , PharmD
Brief Bio : Dr. Etzel is a double alumnus of St. John's University having earned his undergraduate degree in 1988 and Doctor of Pharmacy Degree in 1990. Following his graduate studies, he completed a residency focusing on infectious diseases and pharmacokinetics at Bassett Healthcare in Cooperstown, New York. He joined the faculty of the College of Pharmacy & Allied Health Professions in 1991 as a clinical faculty practitioner in the areas of Internal Medicine and Infectious Diseases. In 2001, he joined the Office of the Dean as Assistant Dean for Pharmacy Student Affairs.
- Summarize the NYS and CDC Guidelines for Pre-Exposure Prophylaxis (PrEP).
- Discuss the efficacy of PrEP in different populations.
- Identify challenges with PrEP.
- Discuss important counseling points for patients receiving prescriptions for PrEP.
John M. Conry, PharmD, AAHIVP, FNAP
Brief Bio : John M. Conry, PharmD, AAHIVP, FNAP; Clinical Professor and Chair, Department of Clinical Health Professions; Director,The Urban Institute, College of Pharmacy and Health Sciences, St. John’s University; Pharmacy Champion, NYSDOH AIDS Institute Clinical Education Initiative.